Career Enhancement Program

职业提升计划摘要/摘要 职业提升计划(CEP)的中心目标是利用MD Anderson的资源进行培训 杰出的年轻研究人员将通过以下途径降低卵巢癌的发病率和死亡率 在该病的早期发现、预防和治疗方面取得进展。为了实现这一目标， 孢子CEP将提供两个奖项，每个奖项每年50,000美元，为期两年，由孢子和 MD Anderson提供的配套资金。每个CEP奖项的目的是让入选的科学家做好准备 成为与卵巢癌相关的学术研究的国际领导者。我们将通过以下方式实现这一目标 积极招聘最有前途的年轻调查人员，并建立一个个性化的 有临床和实验室导师以及指导委员会的发展计划，正式课程工作， 辅导助学金和论文写作，领导力培训，出席国家会议，与 卵巢癌学者正在完成并出版一项翻译的卵巢癌研究计划。 在我们过去的孢子奖中，CEP发展了21名年轻调查人员的职业生涯。在第一年 在最初的拨款中，三名博士后实习生获得了CE奖，而在18名教职员工中， 自2000年以来，所有人都继续从事学术研究，其中13人主要从事卵巢癌。 研究。其中10名获得了同行评审的资助，另外两名获奖者获得了有竞争力的资助。 基金会拨款。在最近的资助周期中，六名获奖者获得了一份R01，一份R03，两份CPRIT 奖项，两项德克萨斯纳米技术中心赠款，一项来自卵巢的Liz Tilberis学者奖 癌症研究基金和苏珊·普尔曼·布莱克卵巢癌赠款。进入节目后， 获奖者发表了500多篇关于卵巢癌的同行评议论文。在教师奖获得者中， 五人是当前孢子的项目负责人、合作调查人员、合作者或核心负责人(Anil Sood博士， 刘劲松、KK Wong、维卡斯·昆德拉和广鹏)。展望未来，CEP将由Anil Sood博士领导， 他是一个杰出的榜样和最有效的导师。

Career Enhancement Program SUMMARY/ABSTRACT The central goal of the Career Enhancement Program (CEP) is to use the resources at MD Anderson to train exceptional young investigators who will reduce the morbidity and mortality from ovarian cancer through making advances in the early detection, prevention, and treatment of this disease. To achieve this goal, the SPORE CEP will provide two awards, each of $50,000 annually for two years, funded from the SPORE and matching funds from MD Anderson. The intent of each CEP award is to prepare the selected scientists to become international leaders in academic research relevant to ovarian cancer. We will achieve this by aggressive recruitment of the most promising young investigators and the institution of an individualized development plan with clinical and a laboratory mentors and a mentoring committee, formal course work, coaching in grant and paper writing, leadership training, attendance at national meetings, networking with ovarian cancer scholars and completing and publishing a translational ovarian cancer research program. During our past SPORE awards, the CEP has developed the careers of 21 young investigators. In the first year of the original grant, three postdoctoral trainees received CE awards, and of the 18 faculty members supported since 2000, all have remained in academic research and 13 are engaged predominantly in ovarian cancer research. Ten have achieved peer-reviewed funding and two additional awardees have received competitive foundation grants. The six awardees in the most recently funded cycle received one R01, one R03, two CPRIT awards, two Texas Center for Nanotechnology Grants, one Liz Tilberis Scholar Award from the Ovarian Cancer Research Fund and one Susan Poorman Blackie Ovarian Cancer grant. After entering the program, awardees have published over 500 peer-reviewed papers regarding ovarian cancer. Of the faculty awardees, five are project leaders, co-investigators, collaborators or core leaders on the current SPORE (Drs. Anil Sood, Jinsong Liu, KK Wong, Vikas Kundra, and Guang Peng). Moving forward, the CEP will be led by Dr. Anil Sood, who is an outstanding role model and most effective mentor.